Junyi Shen

机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0000-0003-2206-5078

发表论文 6 篇 · 总被引 37 次 · h-index 4

代表论文

• Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial (2024 · Trials · 被引 13)
• Spatial confinement modulates endothelial cell behavior and traction force in 3D hydrogel microgrooves (2024 · Materials Today Bio · 被引 9)
• Anisodamine hydrobromide attenuates oxidative stress and proinflammatory cytokines in septic rats induced by cecal ligation and puncture (2022 · Cellular and Molecular Biology · 被引 7)
• DINO-X: A Unified Vision Model for Open-World Object Detection and Understanding (2024 · arXiv (Cornell University) · 被引 4)
• Conversion Resection or Direct Resection for Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicentre Study (2025 · Liver Cancer · 被引 2)
• A POST‐MARKETING SURVEILLANCE STUDY OF 703 PATIENTS TREATED WITH CHIDAMIDE FOR PERIPHERAL T‐CELL LYMPHOMA (PTCL) IN CHINA. HDAC STUDY GROUP OF UNION FOR CHINA LYMPHOMA INVESTIGATORS (UCLI) (2017 · Hematological Oncology · 被引 2)